• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing

I'm Interested in Constellation Brands, Just Not in Love

Question: Would you rather buy the beer or the stock?
By STEPHEN GUILFOYLE
Oct 06, 2021 | 10:38 AM EDT

Groceries were just delivered. True story. Stopped working. It'll be quick. Love being alone. Everything is put neatly in its place rapidly and in good order. Just place the eggs over here... and ooh. There is the Modelo. Is it Friday night? Wednesday morning. I'll have to hold that thought.

Constellation Brands Reports

About an hour before my groceries arrived, Constellation Brands (STZ) reported the firm's fiscal second quarter financial results. The firm posted adjusted EPS of $2.38, missing Wall Street's expectations by more than $0.40. GAAP EPS? Close your eyes. Okay, Just kidding. You can look... $0.01, no joke. However, revenue generation hit the tape at $2.37 billion, which while up a respectable 4.9% from the year ago period, also beat consensus view. What gives? It's complicated, so let's talk.

The EPS of one penny amounts to earnings of $1.5 million, down from $512.1 million for FQ2 last year, or $2.62 a share. Basically, many, many professional athletes brought home more dough than did Constellation this quarter. The problem, aside from rising costs that are industry/economy wide, is their investment in Canadian cannabis/loss center Canopy Growth (CGC) . Ex-Canopy, the wine and spirits business earned $2.57 per share. Cannabis may or may not be a gateway drug, but for Constellation, it is a gateway to something.

Digging In

Going over the statement of operations, net sales as mentioned increased 4.9%. Even away from the investment loss, which came to $470.8 million, down from a loss of $80.7 million a year ago, the firm ran the quarter with general and administrative expenses that gapped 22.8% to $490.5 million. The firm also spent another $29 million extinguishing some outstanding debt. Pretty much explains the gist of it. Rising costs that may have appeared almost, but not quite manageable if not for that hard-hitting loss on the investment made up in the land of ice and snow.

Should investors be concerned? Guess that depends on the cannabis business. We know the beers are quite good. One of you might know if the wines are good. I'm Irish, I have no idea. The firm burned through $357.2 million in cash over three months, and that's really a shame because organically, beer and wine & spirits sales are growing. Let's glance at the balance sheet, Cash, you already know took a hit. Current assets not so much, as there is still enough dough out there in accounts receivable. Let's hope everyone pays their bills.

Current assets are larger than current liabilities, and total assets are significantly larger than total liabilities less equity. I'll tell you one thing I am not crazy about. Okay two things. First, the $486 million in new borrowings that appears for the first time this quarter, and second... $10.081 billion in long-term debt. That's a lot of bread, man. More than a full year's revenue at the current pace. The firm can pay their bills. This is just something to watch, and should Canopy do a little better moving forward, some of this concern abates on its own.

Guidance

Here's a positive. Constellation now expects fiscal full year EPS to span from $10.15 to $10.45, up $0.15 from the firm's prior guidance, and placing the entire range above the $10.03 that Wall Street is looking for. The firm also sees beer sales growing from 9% to 11% from 2021 levels, also above period guidance of 7% to 9%.

Constellation also affirms the operating cash flow target of $2.4 billion to $2.6 billion, and expects free cash flow to land around $1.45 billion. The outlook is certainly positive.

Question

Would you rather buy the beer or the stock? Hmm.

We see on this Wednesday morning the shares trying to break out (two words) of a downward sloping Pitchfork that has been in place since late April. These shares already failed on one breakout (one word) attempt last month. Should this hold, we can then think about retaking the 50 day SMA using the 21 day EMA as support. Failure here could very well send the shares back toward the central trendline of our model. Especially with the broader market looking for reasons to de-risk at least until supply chains unkink, energy shortages abate, Congress gets squared away, and birds sing while children play at the beach on a sunny afternoon.

I would rather buy this name on momentum on a take and hold of that 50 day SMA ($214.83), or sell a few $190 puts going out about six weeks (Nov 19th) for a cool $1.70 or so. Call me interested, but not in love.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Stephen Guilfoyle had no position in the securities mentioned.

TAGS: Earnings | Investing | Markets | Stocks | Technical Analysis | Trading | Beverages | Cannabis

More from Investing

Lopsided Market Returns

James "Rev Shark" DePorre
Jun 5, 2023 4:22 PM EDT

Despite the intraday reversal in Apple, Microsoft, Alphabet, Amazon, and Tesla, all helped the Nasdaq 100 outperform the other indexes as the small caps disappointed.

The Charts -- and the Data -- Support Datadog

Bruce Kamich
Jun 5, 2023 3:35 PM EDT

Here's how DDOG is emerging from a base formation.

Time for Profit-Taking on Palantir

Bruce Kamich
Jun 5, 2023 3:06 PM EDT

Here's my updated look at the charts of Palantir Technologies.

How to Trade MongoDB After Its Huge Upside Move

Bruce Kamich
Jun 5, 2023 1:45 PM EDT

Let's check out the charts and indicators for clues.

This Value Portfolio of Lovable Losers Is Down But Not Out

Jonathan Heller
Jun 5, 2023 1:10 PM EDT

With about six months to go, anything can happen for the 2023 Tax Loss Selling Recovery Portfolio.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 07:19 PM EDT CHRIS VERSACE

    AAP Podcast: This Company Is Not Going 'Solo'

    Listen in as I talk with the very diversified Solo...
  • 01:51 PM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Adjusting Your Trading Approach to Shifting Market...
  • 06:54 PM EDT CHRIS VERSACE

    AAP Podcast: A Tongue -- and a Market -- Twister: 'Get a Debt Deal Done'

    Listen in as the Action Alerts PLUS Podcast tackle...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login